| 生物活性 |
Alnuctamab (EM901) is a bispecific T-cell engager targeting BCMA and CD3, belonging to an asymmetric two-armed humanized IgG1 antibody. Alnuctamab can simultaneously bind to BCMA expressed on the surface of myeloma cells and CD3 molecules on the surface of T cells, recruiting T cells to kill tumors. Alnuctamab is used for the research of multiple myeloma. Recommend Isotype Controls: Human IgG1 kappa, Isotype Control .
|
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 分子量 |
192.13 kDa
|
||||||||||||
| CAS号 |
2296827-07-9
|
||||||||||||
| 运输条件 |
Shipping with dry ice.
|
||||||||||||
| 储存方式 |
|
纯度： 99%
咨询热线：
400-881-9290
Data Sheet
